Transplantation, AutologousHematopoietic Stem Cell TransplantationStem Cell TransplantationTransplantation, HomologousBone Marrow TransplantationMultiple MyelomaPeripheral Blood Stem Cell TransplantationTransplantation ConditioningMelphalanAntineoplastic Combined Chemotherapy ProtocolsBone MarrowCombined Modality TherapyTreatment OutcomeBone Marrow CellsRemission InductionSalvage TherapyStem CellsCyclophosphamideHematopoietic Stem Cell MobilizationDisease-Free SurvivalLymphoma, Non-HodgkinEtoposideBone Marrow PurgingRecurrenceHodgkin DiseaseGraft vs Host DiseaseHematopoietic Stem CellsGranulocytesCarmustineCytarabineMyeloablative AgonistsLiver TransplantationGranulocyte Colony-Stimulating FactorSurvival RateWhole-Body IrradiationGraft SurvivalSurvival AnalysisHematologic NeoplasmsVincristineAntigens, CD34Retrospective StudiesBusulfanThiotepaPrognosisDoxorubicinFollow-Up StudiesKidney TransplantationDexamethasoneTime FactorsLymphoma, Mantle-CellLeukapheresisAmyloidosisCell TransplantationBone and BonesAntineoplastic Agents, AlkylatingAntibodies, Monoclonal, Murine-DerivedThalidomideTransplantation ChimeraBoronic AcidsPyrazinesLymphomaAntineoplastic AgentsTissue DonorsMesenchymal Stem Cell TransplantationLymphoma, FollicularLeukemia, Myeloid, AcutePrednisoneLymphoma, T-Cell, PeripheralNeoplasm, ResidualHematopoiesisAutograftsIfosfamideMyelodysplastic SyndromesCell DifferentiationCord Blood Stem Cell TransplantationImmunosuppressive AgentsHeart TransplantationInduction ChemotherapyPodophyllotoxinLeukemiaCells, CulturedBlood Component RemovalLung TransplantationIdarubicinAntibodies, MonoclonalLymphoma, Large B-Cell, DiffuseProspective StudiesHistocompatibility TestingMaintenance ChemotherapyFeasibility StudiesLeukemia, MyeloidTransplantation ImmunologyGraft RejectionLymphoma, B-CellBone Marrow DiseasesT-LymphocytesHistocompatibilityOrgan TransplantationFlow CytometryMitoxantrone